N-Acetylcysteine amide: A derivative to fulfill the promises of N-Acetylcysteine

Free Radical Research

Volumn 47, Issue 5, 2013, Pages 357-367

  Sunitha, K ^a   Hemshekhar, M ^a   Thushara, R M ^a   Santhosh, M Sebastin ^a   Yariswamy, M ^a   Kemparaju, K ^a   Girish, K S ^a,b  

^a UNIVERSITY OF MYSORE   (India)

^b TUMKUR UNIVERSITY   (India)

Author keywords

Anti apoptotic; Anti inflammatory; N Acetylcysteine; N Acetylcysteine amide; Neuroprotective

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIDE; ANTIOXIDANT; BUTYLCRESOL; CXCL1 CHEMOKINE; DOXORUBICIN; GLUTATHIONE; HALOPERIDOL; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LEAD; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 11; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N ACETYLCYSTEINE AMIDE; PARACETAMOL; PLACEBO; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; ROTENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; APOPTOSIS; BLOOD BRAIN BARRIER; CATARACT; CELL DEATH; CELL MEMBRANE PERMEABILITY; CHO CELL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DENSITY FUNCTIONAL THEORY; DNA FRAGMENTATION; DRUG INTOXICATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; HEART MUSCLE CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LIPOPHILICITY; LUNG PARENCHYMA; MEMBRANE PERMEABILITY; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PARALYSIS; PARKINSON DISEASE; PHAGOCYTOSIS; PHOTOTOXICITY; PNEUMONIA; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; TARDIVE DYSKINESIA; ULTRAVIOLET SPECTROSCOPY;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; CELL SURVIVAL; DRUG THERAPY; GLUTATHIONE; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84876226437     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.781595     Document Type: Review

References (53)

1. Droge W . Free radicals in the physiological control of cell function . Physiol Rev 2002; 82 : 47-95. [Pubmed: 11773609].
2. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J . Free radicals and antioxidants in normal physiological functions and human disease . J Int J Biochem Cell Biol 2007; 39 : 44-84
3. Schulze-Osthoff K, Bauer MK, Vogt M, Wesselborg S . Oxidative stress and signal transduction . Int J Vitam Nutr Res 1997; 67 : 336-342 Pubmed: 9350475].
4. Turpaev KT . Reactive oxygen species and regulation of gene expression . Biochemistry (Mosc) 2002; 67 : 281-292. [Pubmed: 11970728].
5. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J . Role of oxygen radicals in DNA damage and cancer incidence . J Mol Cell Biochem 2004; 266 : 37-56. [Pubmed: 15646026].
6. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M . Free radicals, metals and antioxidants in oxidative stress-induced cancer . Chem Biol Interact 2006; 160: 1- 40. [Pubmed: 16430879].
7. Sies H . Glutathione and its role in cellular functions . Free Radic Biol Med 1999; 27 : 916-921. [Pubmed: 10569624].
8. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND . Glutathione metabolism and its implications for health . J Nutr 2004; 134 : 489-492. [Pubmed: 14988435].
9. Bains JS, Shaw CA . Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 1997; 25: 335- 358. [Pubmed: 9495562].
10. Martin HL, Teismann P . Glutathione-a review on its role and signifi cance in Parkinson ' s disease . FASEB J 2009; 23 : 3263-3272. [Pubmed: 19542204].
11. Ienco EC, LoGerfo A, Carlesi C, Orsucci D, Ricci G, Mancuso M, Siciliano G . Oxidative stress treatment for clinical trials in neurodegenerative diseases . J Alzheimers Dis 2011; 24 : 111-126. [Pubmed: 21422516].
12. Bowie A, O ' Neill LA . Oxidative stress and nuclear factorkappaB activation: A reassessment of the evidence in the light of recent discoveries . Biochem Pharmacol 2000; 59 : 13-23 . [Pubmed: 10605930].
13. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H . Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus . Antioxid Redox Signal 2005; 7 : 395-403. [Pubmed: 15706086].
14. Gloire G, Piette J . Redox regulation of nuclear posttranslational modifi cations during NF-kappaB activation . Antioxid Redox Signal 2009; 11 : 2209-2222. [Pubmed: 19203223].
15. Njalsson R, Norgren S . Physiological and pathological aspects of GSH metabolism . Acta Paediatr 2005; 94 : 132-137. [Pubmed: 15981742].
16. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI . The central role of glutathione in the phatophysiology of human diseases . Arch Physiol Biochem 2007; 113 : 234-258. [Pubmed: 18158646].
17. Halliwell B . Antioxidants in human health and disease . Annu Rev Nutr 1996; 16 : 33-50. [Pubmed: 8839918].
18. Deneke SM . Thiol-based antioxidants . Curr Top Cell Regul 2000; 36 : 151-180. [Pubmed: 10842751].
19. Zafarullah M, Li WQ, Sylvester J, Ahmad M . Molecular mechanisms of N-acetylcysteine actions . Cell Mol Life Sci 2003; 60 : 6-20. [Pubmed: 12613655].
20. Dodd S, Dean O, Copolov DL, Malhi GS, Berk M . Nacetylcysteine for antioxidant therapy: Pharmacology and clinical utility . Expert Opin Biol Ther 2008; 8 : 1955-1962. [Pubmed: 18990082].
21. Pei P, Horan MP, Hille R, Hemann CF, Schwendeman SP, Mallery SR . Reduced nonprotein thiols inhibit activation and function of MMP-9: Implications for chemoprevention . Free Radic Biol Med 2006; 41 : 1315-1324. [Pubmed: 17015178].
22. Sunitha K, Hemshekhar M, Santhosh MS, Kumar MS, Kemparaju K, Girish KS . Inhibition of hemorrhagic activity of viper venoms by N-acetyl cysteine: Involvement of N-acetyl and thiol groups . Curr Top Med Chem 2011; 11 : 2589-2600. [Pubmed:21682678].
23. Kelly GS . Clinical applications of N-acetylcysteine . Altern Med Rev 1998; 3 : 114-127. [Pubmed: 9577247].
24. Millea PJ . N-acetylcysteine: Multiple clinical applications . Am Fam Physician 2009; 80 : 265-269. [Pubmed: 19621836].
25. Aitio ML . N-acetylcysteine-passe-partout or much ado about nothing? . Br J Clin Pharmacol 2006; 61 : 5-15. [Pubmed: 16390346].
26. Atlas D, Melamed E, Off en D . Brain targeted low molecular weight hydrophobic antioxidant compounds . U.S. Patent 5,874,468, 1999, February 22
27. Off en D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R, et al . A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis . J Neurochem 2004; 89 : 1241-1251. [Pubmed: 15147517].
28. Ates B, Abraham L, Ercal N . Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC) . Free Radic Res 2008; 42 : 372-377. [Pubmed: 18404536].
29. Annia G . Mechanism and kinetics of the hydroxyl and hydroperoxyl radical scavenging activity of N-acetylcysteine amide . Theor Chem Acc 2011; 130 : 51-60
30. Chen W, Ercal N, Huynh T, Volkov A, Chusuei CC . Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment . J Colloid Interface Sci 2012; 371 : 144-149. [Pubmed: 22284448].
31. Grinberg L, Fibach E, Amer J, Atlas D . N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic Biol Med 2005; 38: 136- 145. [Pubmed: 15589382].
32. Amer J, Atlas D, Fibach E . N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells . Biochim Biophys Acta 2008 ; 1780 : 249-255. [Pubmed: 18082636].
33. Carey JW, Pinarci EY, Penugonda S, Karacal H, Ercal N . In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide . Free Radic Biol Med 2011; 50 : 722-729. [Pubmed: 21172425].
34. Schimel AM, Abraham L, Cox D, Sene A, Kraus C, Dace DS, et al . N-acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation . Am J Pathol 2011; 178 : 2032-2043. [Pubmed: 21457933].
35. Shi R, Huang CC, Aronstam RS, Ercal N, Martin A, Huang YW . N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes . BMC Pharmacol 2009; 15 : 9-7. [Pubmed: 19368719].
36. Wu W, Abraham L, Ogony J, Matthews R, Goldstein G, Ercal N . Eff ects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells . Life Sci 2008; 82 : 1122-1130. [Pubmed: 18448127].
37. Whitaker BD, Knight JW . Eff ects of N-acetyl-cysteine and N-acetyl-cysteine-amide supplementation on in vitro matured porcine oocytes . Reprod Domest Anim 2010; 45 : 755-759. [Pubmed: 19220795].
38. Gong X, Celsi G, Carlsson K, Norgren S, Chen M . Nacetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling . Am J Nephrol 2010; 31 : 178-188. [Pubmed: 20016144].
39. Gong X, Celsi G, Carlsson K, Norgren S . Protective eff ects of N-acetylcysteine amide (NACA) on gentamicin-induced apoptosis in LLC-PK1 cells. Ren Fail 2012; 34: 487- 494. [Pubmed: 22486232].
40. Lee KS, Kim SR, Park HS, Park SJ, Min KH, Lee KY, et al . A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease byregulating activation of NF-kappaB and hypoxia-inducible factor-1alpha . Exp Mol Med 2007; 39 : 756-768. [Pubmed: 18160846].
41. Chavko M, Adeeb S, Ahlers ST, McCarron RM . Attenuation of pulmonary inflammation after exposure to blast overpressure by N-acetylcysteine amide . Shock 2009; 32 : 325-331. [Pubmed: 19174737].
42. Banerjee A, Trueblood MB, Zhang X, Manda KR, Lobo P, Whitefi eld PD, et al . N-acetylcysteineamide (NACA) prevents inflammation and oxidative stress in animals exposed to diesel engine exhaust . Toxicol Lett 2009; 187 : 187-193. [Pubmed: 19429263].
43. Gilgun-Sherki Y, Barhum Y, Atlas D, Melamed E, Off en D . Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant. J Mol Neurosci 2005; 27: 125-135. [Pubmed: 16055951].
44. Bahat-Stroomza M, Gilgun-Sherki Y, Off en D, Panet H, Saada A, Krool-Galron N, et al. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson ' s disease . Eur J Neurosci 2005; 21 : 637-646. [Pubmed: 15733082].
45. Sadan O, Bahat-Stromza M, Gilgun-Sherki Y, Atlas D, Melamed E, Off en D. A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement inrats: Implications for tardive dyskinesia . Clin Neuropharmacol 2005; 28 : 285-288. [Pubmed: 16340385].
46. Bartov O, Sultana R, Butterfi eld DA, Atlas D . Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from Abeta(1-42) toxicity . Brain Res 2006; 1069 : 198-206
47. Penugonda S, Mare S, Goldstein G, Banks WA, Ercal N . Eff ects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12 . Brain Res 2005; 1056 : 132-138. [Pubmed: 16120436].
48. Penugonda S, Mare S, Lutz P, Banks WA, Ercal N . Potentiation of lead-induced cell death in PC12 cells by glutamate: Protection by N-acetylcysteine amide (NACA), a novel thiol antioxidant . Toxicol Appl Pharmacol 2006; 216 : 197-205. [Pubmed: 16781745].
49. Penugonda S, Ercal N . Comparative evaluation of Nacetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice . Toxicol Lett 2011; 201 : 1-7. [Pubmed: 21145953].
50. Price TO, Uras F, Banks WA, Ercal N. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells . Exp Neurol 2006; 201 : 193-202. [Pubmed: 16750528].
51. Zhang X, Banerjee A, Banks WA, Ercal N . N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells . Brain Res 2009; 1275 : 87-95. [Pubmed: 19374890].
52. Banerjee A, Zhang X, Manda KR, Banks WA, Ercal N . HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in thebrain: Potential role of the thiol antioxidant N-acetylcysteine amide . Free Radic Biol Med 2010; 48 : 1388-1398. [Pubmed: 20188164].
53. Manda KR, Banerjee A, Banks WA, Ercal N . Highly active antiretroviral therapy drug combination induces oxidative stress andmitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells . Free Radic Biol Med 2011; 50 : 801-810. [Pubmed: 21193030].